文献速递临床试验与 GCP

中医耳穴按压缓解新冠疫苗接种后疼痛、疲劳及胃肠道不良反应:多中心三臂单盲前瞻性随机对照试验方案摘要

Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial.
PubMed 文献 · Trials · 2021-02-25

本研究为多中心、三臂、单盲、前瞻性随机对照试验,计划纳入不少于360名接种新冠疫苗的健康人,按1:1:1随机分为中医耳穴按压组、假耳穴按压组和空白对照组,评估耳穴按压对接种后疼痛、疲劳及胃肠道不良反应的缓解效果。

要点

  • 耳穴按压组在5个耳穴(双侧共10点)进行症状特异性按压,每次接种后持续5天。
  • 主要结局为接种后即刻、3天、7天和15天的VAS评分,涵盖注射部位疼痛、头痛、肌肉关节痛、疲劳及胃肠道症状。
  • 试验采用计算机随机分组,参与者、信息收集者和统计评估者在耳穴按压组与假按压组间设盲。

核心结论

  • 该方案旨在评估中医耳穴按压能否减轻新冠疫苗接种后的疼痛、疲劳和胃肠道不良反应。

研究设计与样本

  • 多中心、平行组、三臂、单盲、前瞻性随机(1:1:1)对照试验,计划从中国四川省5个社区卫生服务中心和1所大学医院招募不少于360名健康疫苗接种者。

主要发现

  • 原文未报告结果。

关键数值与推荐

  • 纳入标准包括18-59岁、完成首剂接种24小时内入组、双耳皮肤无红肿损伤感染、无酒精和胶带接触过敏史等。
  • 排除标准包括疫苗接种禁忌或谨慎人群、4周内参与其他临床试验、接种前无慢性/习惯性/持续性头痛、肌肉或关节痛、疲劳、腹泻、恶心、干呕或呕吐及相关疾病、2周内使用或接受过中医耳穴按压、妊娠或哺乳期妇女、其他严重原发病及精神病患者。
  • 干预组接受双侧5个耳穴(每侧5点,双侧共10点)的症状特异性中医耳穴按压,每次接种后持续5天,每天自行按压3-4次(每次约1分钟),共10天。
  • 假按压组接受双侧5个耳穴的非症状特异性假耳穴按压,频次和时长同干预组;空白对照组不干预。
  • 主要结局为基于参与者主观判断的视觉模拟量表(VAS)所有评分,包括注射部位疼痛、头痛、肌肉和关节痛、疲劳、恶心、干呕、呕吐和腹泻的VAS评分,评估时间点为每次接种后即刻(基线)、3天、7天和15天。

临床怎么用

  • 原文未报告临床实践建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate if traditional Chinese medicine (TCM) auricular point acupressure (APA) can alleviate and (or) reduce the pain (including injection site pain, headache, other muscle and joint pain), fatigue, and gastrointestinal adverse reactions (including nausea, vomiting, diarrhea), after the injection of novel coronavirus-19 vaccines (NCVs). TRIAL DESIGN: The study is designed as a multicentre, parallel-group, three-arm, single-blind, prospective, randomized (1:1:1 ratio) study. PARTICIPANTS: More than 360 participants will be recruited from healthy people who vaccinate NCVs in 5 community healthcare centres in the Sichuan province of China and 1 university hospital (Hospital of Chengdu University of Traditional Chinese Medicine). INCLUSION CRITERIA: ①Vaccinators meets the conditions of NCVs injection and have no contraindications to it. The details shall be subject to the instructions of the NCVs used and the statement of medical institutions. The first dose of NCVs injection shall be completed within 24 hours from the time of injection to the time of enrolment; ②No redness, swelling, injury or infection of the skin or soft tissue of both ears, which is not suitable for APA; ③No history of alcohol and adhesive tape contact allergy; ④18-59 years old, regardless of gender; ⑤Those who were able to complete the questionnaire independently at the time of the first and second dose of NCVs and on the 3rd, 7th and 15th day after the first and second dose of NCVs respectively; ⑥Those who agree to participate in the trial and sign the informed consent, and can seriously abide by the precautions after the injection of NCVs and the requirements of traditional Chinese medicine auricular point plasters sticking and acupressure. EXCLUSION CRITERIA: ①Those who are not suitable to be vaccinated because they belong to the contraindication or cautious population; ②Those who have participated in other clinical trials within 4 weeks before the start of this study; ③No chronic/habitual/persistent headache, Muscle or joint pain, fatigue, diarrhea, nausea, retching or vomiting before the injection of NCVs, and no related diseases present (details of this item is listed in full protocol); ④Those who are in use or have received TCMAPA within 2 weeks before the trial; ⑤Pregnant or lactating women; ⑥Participants with other serious primary diseases and psychosis. INTERVENTION AND COMPARATOR: ①Auricular point acupressure group: participants receive bilateral, symptom-specific TCMAPA in 5 auricular points (per side, 10 points bilateral) for 5 days, 3-4 times (about 1 min each time) of self-acupressure per day, after each NCVs injection (10 days in total). ②Sham auricular point acupressure group: participants receive bilateral, none symptom-specific, sham APA in 5 auricular points (per side, 10 points bilateral) for 5 days, 3-4 times (about 1 min each time) of self-acupressure per day, after each NCVs injection (10 days in total). ③Blank control group: Non-intervention blank control. The Hebei medical device Co. Ltd, Hebei, China manufactured the auricular point sticking plasters. MAIN OUTCOMES: Primary outcomes are all scores of visual analogue scale (VAS) based on subjective judgment of the participants included, including VAS score of pain at injection site, headache, muscle and joint pain, fatigue, nausea, retching, vomiting and diarrhea. Time points for outcomes above are the same: ①Immediately after first and second injection of the vaccine (Baseline assessment); ②Three days after first and second injection of the vaccine; ③Seven days after first and second injection of the vaccine; ④Fifteen days after first and second injection of the vaccine. RANDOMISATION: Participants will be randomized in 1:1:1 ratio to each group by computerized random number generator, and independently in each sub-centre. BLINDING (MASKING): Participants, information collectors and statistical evaluators will be blinded between APA group and sham APA group. No blinding in the control group. NUMBERS TO BE RANDOMISED (SAMPLE SIZE): No less than 360 participants will be randomized in 1:1:1 ratio to each group. TRIAL STATUS: Protocol version 2.0 of February 3rd, 2021. Recruitment is expected to start on February 18th, 2021, and to finish on March 12th, 2021. TRIAL REGISTRATION: This trial was registered in the China Clinical Trial Registry (ChiCTR) ( ChiCTR2100043210 ) on 8th February, 2021. FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Fu Q, Xie H, Zhou L, et al. Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial. Trials. 2021. PMID: 33632286. doi:10.1186/s13063-021-05138-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。